Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/8/2025

Amoxicillin-Clavulanate Dosing for Preseptal Cellulitis and Bacterial Conjunctivitis

Rationale for Amoxicillin-Clavulanate Selection

  • The American Academy of Pediatrics recommends high-dose amoxicillin-clavulanate for patients with concurrent conjunctivitis due to increased likelihood of Haemophilus influenzae and Moraxella catarrhalis involvement 2, 4
  • Standard amoxicillin alone is insufficient for the otitis-conjunctivitis syndrome or preseptal cellulitis due to the higher likelihood of β-lactamase-producing organisms 1, 3
  • The combination provides coverage against both Streptococcus pneumoniae and β-lactamase-producing pathogens commonly found in these infections 3, 4

Specific Dosing Recommendations

  • High-dose formulation for pediatric patients: 90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate divided in 2 doses 1, 2
  • This 14:1 ratio formulation is less likely to cause diarrhea than other amoxicillin-clavulanate preparations 3

Alternative Treatments for Penicillin-Allergic Patients

  • For non-type I penicillin allergy: Cefdinir (14 mg/kg/day in 1-2 doses), cefuroxime (30 mg/kg/day in 2 doses), or cefpodoxime (10 mg/kg/day in 2 doses) 1, 2
  • For type I penicillin allergy: Clindamycin (30-40 mg/kg/day in 3 divided doses) with or without a third-generation cephalosporin 1, 5

Monitoring and Follow-up

  • Clinical improvement should be evident within 48-72 hours of initiating appropriate therapy 2, 4
  • If no improvement after 48-72 hours, consider treatment failure and switch to an alternative antibiotic regimen 1, 3

Common Pitfalls

  • Inadequate dosing of amoxicillin component when treating potentially resistant organisms 3, 4